Amgen (AMGN) Inventory Average (2009 - 2026)

Amgen has reported Inventory Average for 17 years, with the latest figure at $6.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 9.59% year-over-year to $6.2 billion; the trailing twelve-month figure through Mar 2026 stood at $6.2 billion (down 9.59% YoY), and the FY2025 full-year result was $6.6 billion, down 19.94% from the prior year.
• Inventory Average for Q1 2026 stood at $6.2 billion, down from $6.3 billion in the prior quarter.
• The five-year high for Inventory Average was $9.1 billion in Q1 2024, with the low at $4.2 billion in Q1 2022.
• Average Inventory Average over 5 years is $6.2 billion, with a median of $6.3 billion recorded in 2025.
• Year-over-year, Inventory Average soared 83.5% in 2024 and decreased 24.75% in 2025.
• Tracing AMGN's Inventory Average over 5 years: stood at $4.8 billion in 2022, then surged by 50.14% to $7.3 billion in 2023, then declined by 1.27% to $7.2 billion in 2024, then retreated by 12.46% to $6.3 billion in 2025, then retreated by 1.27% to $6.2 billion in 2026.
• The last three Inventory Average figures came in at $6.2 billion (Q1 2026), $6.3 billion (Q4 2025), and $6.5 billion (Q3 2025), per Business Quant data.

Peer Comparison